Karen M Redwine1, Laura P James, MaryAnn O'Riordan, Janice E Sullivan, Jeffrey L Blumer. 1. aDepartment of Pediatrics, Division of Pediatric Nephrology bDepartment of Pediatrics, Section of Clinical Pharmacology and Toxicology, University of Arkansas for Medical Sciences & Arkansas Children's Hospital, Little Rock, Arkansas cDepartment of Pediatrics, Division of Pediatric Critical Care, Case Western Reserve University Hospitals, Cleveland dDepartment of Pediatrics, University of Toledo, Toledo, Ohio Departments of ePediatrics fPharmacology/Toxicology, Divisions of Pediatric Critical Care and the Kosair Charities Pediatric Clinical Research Unit, University of Louisville, Louisville, Kentucky gNational Institute of Child Health and Human Development, Rockville, Maryland, USA.
Abstract
BACKGROUND: Ambulatory blood pressure monitoring techniques provide unique advantages for diagnosing hypertension, although few devices have been independently validated in the pediatric population. METHODS: We sought to validate the accuracy of ambulatory blood pressure monitoring with the Spacelabs 90217 monitor in children using a modified British Hypertension Society protocol. RESULTS: A total of 112 children, aged between 6 and 17 years, completed the study at one of the three participating centers. Overall, the monitor earned an 'A' for systolic blood pressure and 'B' for diastolic blood pressure. It performed slightly better among 6-12 year olds (A/A) compared with 13-17 year olds (A/B). CONCLUSIONS: We conclude that the Spacelabs 90217 monitor is an appropriate monitor for use in children who are 6 years of age or older.
BACKGROUND: Ambulatory blood pressure monitoring techniques provide unique advantages for diagnosing hypertension, although few devices have been independently validated in the pediatric population. METHODS: We sought to validate the accuracy of ambulatory blood pressure monitoring with the Spacelabs 90217 monitor in children using a modified British Hypertension Society protocol. RESULTS: A total of 112 children, aged between 6 and 17 years, completed the study at one of the three participating centers. Overall, the monitor earned an 'A' for systolic blood pressure and 'B' for diastolic blood pressure. It performed slightly better among 6-12 year olds (A/A) compared with 13-17 year olds (A/B). CONCLUSIONS: We conclude that the Spacelabs 90217 monitor is an appropriate monitor for use in children who are 6 years of age or older.
Authors: Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella Journal: Hypertension Date: 2004-12-20 Impact factor: 10.190
Authors: Alexander C Egbe; William R Miranda; Likhita Shaik; Renuka Reddy Katta; Ahmed Goda Sakr; Janaki Devara; Heidi M Connolly Journal: Blood Press Monit Date: 2022-04-01 Impact factor: 1.444
Authors: Erin Hessey; Alex Paun; Kelly Benisty; Kelly McMahon; Ana Palijan; Michael Pizzi; Catherine Morgan; Michael Zappitelli Journal: Pediatr Nephrol Date: 2022-01-17 Impact factor: 3.651
Authors: Joyce P Samuel; Cynthia S Bell; Sean A Hebert; Arun Varughese; Joshua A Samuels; Jon E Tyson Journal: Blood Press Monit Date: 2017-12 Impact factor: 1.444